Clinical Trials Logo
  1. Home
  2. Other Cancer
  3. NCT03244826

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Other Cancer Clinical Trial

Official title:
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Clinical Trial Summary

This research study aims to evaluate the effectiveness of allowing patients who have had a hematopoietic cell transplant to receive some of their post-transplant care with a local oncologist rather than returning to the transplant center for all of their follow-up.

Clinical Trial Description

Hematopoietic Cell Transplantation (HCT) - also known as bone marrow transplant - is only available at select centers in the United States which can collect and store stem cells, as well as care for patients before their new immune system cells take hold. For this reason, many patients who undergo HCT live at great distances from their HCT center. Also, after hospital discharge, the first 180 days post-HCT are very important, as patients must be managed closely with frequent follow-up visits. A potential way to make life easier for HCT patients is to allow some of the post-transplant care to be provided by local oncologists who practice closer to where patients live. This could reduce the burden on patients and their caregivers; however, it is not known if a shared care model would ultimately benefit them. The investigators want to assess the effectiveness of a Shared Care program which allows patients to receive half of their post-HCT care at the HCT center, and the other half with their local oncologist ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03244826
Study type Interventional
Source Dana-Farber Cancer Institute
Contact
Status Completed
Phase N/A
Start date January 1, 2018
Completion date August 22, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04340024 - Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Active, not recruiting NCT03609177 - Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly N/A
Active, not recruiting NCT04591431 - The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy Phase 2
Recruiting NCT06103669 - Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) N/A
Recruiting NCT04585750 - The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Phase 1/Phase 2
Recruiting NCT03160274 - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed NCT03736746 - Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals N/A
Not yet recruiting NCT06397651 - A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care N/A
Completed NCT03638453 - Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention N/A
Active, not recruiting NCT03850912 - Symptom Management Implementation of Patient Reported Outcomes in Oncology N/A
Completed NCT03392090 - SHARE (Sharing Goals and Preferences) Study N/A
Recruiting NCT03517332 - Circulating Tumor DNA Exposure in Peripheral Blood
Completed NCT03721926 - A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer N/A
Active, not recruiting NCT03967379 - Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors N/A
Completed NCT05176860 - Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy N/A
Active, not recruiting NCT03674047 - Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) Phase 2
Active, not recruiting NCT03752268 - Development of an Intervention to Enhance Cancer Pain Management N/A